INCYTE CORP ($INCY)
Filing Information
| Accession Number | 0001205703-26-000032 |
|---|---|
| Form Type | 4 |
| Filing Date | Oct 19, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
7,926
Total Value
$471,521.72
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President, Global Head of R&D | Common Stock | โ | Oct 15, 2026 | Exercise/Conversion | 839 | $71.93 | $60,349.27 | 184,039 | Direct | โ | View Details | |
President, Global Head of R&D | Common Stock | โ | Oct 15, 2026 | Exercise/Conversion | 423 | $61.76 | $26,124.48 | 184,462 | Direct | โ | View Details | |
President, Global Head of R&D | Common Stock | โ | Oct 15, 2026 | Exercise/Conversion | 455 | $61.18 | $27,836.90 | 184,917 | Direct | โ | View Details | |
President, Global Head of R&D | Common Stock | โ | Oct 15, 2026 | Exercise/Conversion | 925 | $64.25 | $59,431.25 | 185,842 | Direct | โ | View Details | |
President, Global Head of R&D | Common Stock | โ | Oct 15, 2026 | Sale | 2,642 | $112.71 | $297,779.82 | 183,200 | Direct | โ | View Details | |
President, Global Head of R&D | Employee Stock Option (right to buy) | Derivative | Oct 15, 2026 | Exercise/Conversion | 839 | $0.00 | $0.00 | 17,627 | Direct | โ | View Details | |
President, Global Head of R&D | Employee Stock Option (right to buy) | Derivative | Oct 15, 2026 | Exercise/Conversion | 423 | $0.00 | $0.00 | 3,802 | Direct | โ | View Details | |
President, Global Head of R&D | Employee Stock Option (right to buy) | Derivative | Oct 15, 2026 | Exercise/Conversion | 455 | $0.00 | $0.00 | 4,096 | Direct | โ | View Details | |
President, Global Head of R&D | Employee Stock Option (right to buy) | Derivative | Oct 15, 2026 | Exercise/Conversion | 925 | $0.00 | $0.00 | 19,431 | Direct | โ | View Details |